JPRN-jRCT2080221673未知1 期
A multi-center, parallel-group comparison, double-blind, placebo-controlled, randomized, trial to determine the safety, pharmacokinetics, and efficacy of OPC-108459 administered as a single intravenous dose to subjects with paroxysmal or persistent atrial fibrillation (Phase 1 trial)
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with a diagnosis with paroxysmal and persistent atrial fibrillation
排除标准
- •Heart failure, complication of atrial flutter, history of myocardial infarction and angina pectoris, etc.
研究者
相似试验
未知
1 期
A Multicenter, Parallel-group-comparison, Double-blind, Placebo-controlled, Randomized Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial FibrillatioParoxysmal or Persistent Atrial FibrillationJPRN-jRCT2080222398Otsuka Pharmaceutical Co., Ltd.
招募中
不适用
Parallel-group, multicenter, comparative study on the usefulness of nutrition therapy for patients with Crohn's disease Infliximab maintenance therapys diseaseCrohn's diseaseJPRN-UMIN000010293Graduate School of Medical Sciences, Kyushu University80
未知
4 期
A multi-center,_double-blind,_pararel-group comparison phase 4 trial to investigate the effect of tolvaptan on mid- to long-term prognosis of heart failure patientsVolume overload in heart failure that does not respond adequately to other diuretics (e.g., loop diuretics)JPRN-jRCT1080221581Otsuka Pharmaceutical Co., Ltd.100
已完成
不适用
A prospective,multi-center,parallel-group comparison study to evaluate safety and efficacy of dabigatran during the perioperative period in patients with non-valvular atrial fibrillation who undergo the catheter ablation compared to walfariJPRN-UMIN000013129Research group of anticoagulation therapy for NVAF ablation450
进行中（未招募）
不适用
A multi-center, randomized, parallel-group, comparative, active-controlled, safety-assessor blinded trial in adult subjects comparing the efficacy and safety of sugammadex administered at 1-2 PTC with neostigmine administered at reappearance of T2 in subjects undergoing laparoscopic cholecystectomy or appendectomy under propofol anesthesia - MoonlightEUCTR2007-007951-14-FIV Organon140